GeneOhm Sciences

GeneOhm Sciences is a company that designs, develops, and delivers nucleic acid-based diagnostic solutions aimed at addressing unmet diagnostic needs across various diseases, including inherited diseases, infectious diseases, and oncology. Based in San Diego, California, and established in 2001, GeneOhm focuses on developing rapid diagnostic systems that can detect and identify infectious agents and genetic variations, providing results in under two hours. The company offers specific diagnostic tests, including an assay for methicillin-resistant Staphylococcus aureus (MRSA) and a test for Group B Streptococcus in pregnant women. Additionally, GeneOhm's technology includes a lysis kit for processing various sample types. In 2004, GeneOhm merged with Infectio Diagnostic, Inc., enhancing its portfolio with proprietary technology and industry expertise. The company was later acquired by the BD Pharmaceuticals group, further solidifying its position in the molecular diagnostics field.